Chabiotech Co.,Ltd. (KOSDAQ: 085660)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,860
-380 (-2.49%)
Dec 20, 2024, 9:00 AM KST

Chabiotech Co.,Ltd. Company Description

Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally.

The company provides an umbilical cord blood consignment storage for the treatment of incurable diseases; regenerative medicines, immune cell and stem cell storage services, anti-aging, and solutions for incurable diseases; medical wellness programs, comprising fitness, spa, and scupplements; and customized development, production, clinical, and commercialization services to customers with research and development, and clinical experience.

It offers optimized IT system construction and operation; consulting services for development, operation, and expansion of Chaum model; and solutions for maternal-centered genome testing and personalized healthcare.

In addition, the company develops immune cells, such as CBT101 for recurrent glioblastoma and solid cancer, and CBT111 and CAR-NK for solid cancer; and stem cells, including CordSTEM-DD for chronic back pain, CordSTEM-POI for premature ovarian failure, CordSTEM-ST for stroke, CBT-NPC for Parkinson’s disease, and hESC-RPE for macular degeneration and Stargardt’s disease.

Further, it offers IVF (fertility) services; cosmetics and cosmetic raw materials; medical devices and supplies; bioinsurance storage; research services; and other services.

The company was founded in 2002 and is headquartered in Seoul, South Korea.

Chabiotech Co.,Ltd.
Country South Korea
Founded 2002
Industry Ophthalmic Goods
Employees 292
CEO Hoon Oh Sang

Contact Details

Address:
442 Dosan-daero
Seoul
South Korea
Phone 82 3 1881 7400
Website chabio.com

Stock Details

Ticker Symbol 085660
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 3851

Key Executives

Name Position
Hoon Oh Sang Chief Executive Officer